Advocates for Universal DPD/DPYD Testing
Advocates for Universal DPD/DPYD Testing is a patient advocacy organization whose mission is to improve the standard of care in the United States for cancer patients undergoing fluoropyrimidine chemotherapy (5-FU and/or Capecitabine). Testing for DPD/DPYD deficiency prior to the start of chemotherapy with 5-FU (Fluorouracil) or Capecitabine (Xeloda) can reduce suffering and save lives. This testing is becoming standard of care across Europe and in select institutions in the US. It is time for it to become THE standard of care across all the US.